Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BIO.WA
HoldBargain BinBIOTON S.A. · Healthcare · Poland · $87M · Avg Vol: $27K/d
COMPANY DESCRIPTION
BIOTON S.A. is a biotechnology company specializing in the development, manufacture, and distribution of recombinant human insulin and insulin analogues. As one of only a few global producers of active pharmaceutical ingredients (API) for insulin, the company possesses a highly defensible technological moat. It operates a vertically integrated biotech platform, targeting high-growth emerging markets where diabetes prevalence is rising.
FINANCIAL SUMMARY (PLN)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 233.2M | 181.6M | 207.8M | 282.5M | 6.6% | 266.0M |
| EPS (PLN) | 0.02 | 0.03 | -0.18 | 0.04 | 26.0% | 0.05 |
| Shares | 85.9M | 85.9M | 85.9M | 85.9M | 0.0% | 85.9M |
| Debt | 76.4M | 68.7M | 56.6M | 57.2M | -9.2% | 58.8M |
| Equity | 604.1M | 606.4M | 590.5M | 594.0M | -0.6% | — |
| Op CF | 56.1M | 39.6M | 36.3M | 22.6M | -26.1% | 18.1M |
| Inv CF | -29.1M | -37.0M | -11.2M | -13.0M | — | — |
| Fin CF | -26.5M | -8.1M | -22.1M | -8.3M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BIO.WA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BIO.WA | BIOTON S.A.(you) | $87M | 51 | Hold |
| BCX.WA | Bioceltix S.A. | $118M | 18 | Strong Sell |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | $120M | 6 | Strong Sell |
| SVE.WA | Synthaverse S.A. | $46M | 11 | Strong Sell |
| RVU.WA | Ryvu Therapeutics S.A. | $113M | 4 | Strong Sell |
| MOC.WA | Molecure S.A. | $40M | 14 | Strong Sell |
| PTG.WA | Poltreg S.A. | $34M | 13 | Strong Sell |
| S2B.WA | Syn2bio S.A. | $148M | 3 | Strong Sell |
| NNG.WA | NanoGroup S.A. | $28M | 14 | Strong Sell |
| MAB.WA | Mabion S.A. | $34M | 10 | Strong Sell |
Peer medians: ROE -19.0% · P/E 15.8x · Gross margin 30.1%